Dr Reddys Stock In The News

Dr Reddys stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Dr Reddys earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Dr Reddys that is available to investors today. That information is available publicly through Dr Reddys media outlets and privately through word of mouth or via Dr Reddys internal channels. However, regardless of the origin, that massive amount of Dr Reddys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dr Reddys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dr Reddys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dr Reddys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dr Reddys alpha.

Dr Reddys Largest EPS Surprises

Earnings surprises can significantly impact Dr Reddys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Dr Reddys Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Dr Reddys Laboratories Stock. Current markets are slightly bullish. About 51% of major world exchanges and indexes are currently up. See today's market update for more information.
28th of June 2022
Dr Reddys Labs announces conclusion of patent litigation with Indivior - Indiainfoline
at www.indiainfoline.com 
22nd of June 2022
Barometers trade with steep losses - Business Standard
at www.business-standard.com 
13th of June 2022
Dr Reddys Lab launches Nexavar generic in US mkt - Business Standard
at www.business-standard.com 
9th of June 2022
Market snaps 4-day losing streak Nifty ends above 16,450 - Business Standard
at www.business-standard.com 
2nd of June 2022
Torrent Acquires Chronic Brands From Dr Reddys, Folds Up US Liquids Business - Generics Bu...
at generics.pharmaintelligence.informa.com 
25th of May 2022
Dr. Reddys Laboratories and Senores Pharmaceuticals, Inc. announces the launch Ketorolac T...
at www.equitybulls.com 
cnbc News
18th of May 2022
ITC, Ashok Leyland, IndiGo, BPCL, Bosch, Dr Reddys and more Top stocks to watch on May 19 ...
at www.cnbctv18.com 
Investing News at Macroaxis
12th of May 2022
India stocks lower at close of trade Nifty 50 down 2.22 percent By Investing.com - Investi...
at www.investing.com 
9th of May 2022
US Wall Street tumbles to one-year lows - Business Standard
at www.business-standard.com 
13th of April 2022
Stock Market Today Sensex falls 237 points, Nifty settles below 17,500-mark weighed by HDF...
at indianexpress.com 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Dr Reddys without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now


Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at Dr Reddys Backtesting and Dr Reddys Hype Analysis. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Dr Reddys Stock analysis

When running Dr Reddys Laboratories price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know Dr Reddys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
9.3 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of Dr Reddys that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine Dr Reddys value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

USD 55.84  0.45  0.81%   

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Dr Reddys and other traded companies coverage. We help investors stay connected with Dr Reddys headlines for the 3rd of July to make an informed investment decision based on correlating the impacts of news items on Dr Reddys Stock performance. Please note that trading solely based on the Dr Reddys Laboratories hype is not for everyone as timely availability and quick action are needed to avoid losses.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Dr Reddys headlines in addition to utilizing other, more conventional financial analysis modules. Additionally, take a look at Dr Reddys Backtesting and Dr Reddys Hype Analysis.
Dr Reddys' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Dr Reddys Laboratories investors visualize upcoming and past events in order to time the market based on Dr Reddys Laboratories noise-free hype analysis.